歐洲放射治療市場、份額和趨勢分析報告—產業概覽和 2032 年預測

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Pharmaceutical Europe Radiotherapy Market
请求目录 请求目录 与分析师交谈 与分析师交谈 免费样本报告 免费样本报告 购买前请咨询 提前咨询 立即购买 立即购买

歐洲放射治療市場、份額和趨勢分析報告—產業概覽和 2032 年預測

  • Pharmaceutical
  • Published Report
  • Dec 2023
  • Europe
  • 350 页面
  • 桌子數： 197
  • 图号： 39
立即购买 立即购买 索取樣品 索取樣品
Nucleus Nucleus

通过敏捷供应链咨询解决关税挑战

供应链生态系统分析现已成为 DBMR 报告的一部分

Europe Radiotherapy Market

市场规模（十亿美元）

CAGR :  % Diagram

Chart Image USD 2.41 Billion USD 4.89 Billion 2024 2032
Diagram Forecast Period
 2025 –2032
Diagram Market Size (Base Year)
 USD 2.41 Billion
Diagram Market Size (Forecast Year)
 USD 4.89 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • Siemens Healthcare GmbH
  • Hitachi Ltd.
  • General Electric Company
  • Koninklijke Philips N.V.
  • Elekta

歐洲放射治療市場，依產品和服務（服務、產品和軟體）、類型（外束放射治療、內放射治療、全身放射治療/放射性藥物等）、應用（乳腺癌、肺癌、前列腺癌、結直腸癌、淋巴瘤、肝癌、甲狀腺癌、腦癌、子宮頸癌、脊柱癌等）、最終用戶（醫院、分銷

歐洲放射治療市場

歐洲放射治療市場規模

  • 2024 年歐洲放射治療市場規模為24.1 億美元 ，預計 2032年將達到48.9 億美元，預測期內複合年增長率為 9.7%。
  • 市場的成長源於癌症盛行率的不斷增長、癌症治療放射治療的新技術以及放射治療設備和程序的日益普及
  • 此外，預計市場將增加用於癌症治療的醫療支出，政府將增加對癌症治療的投入，患者對癌症治療的認識也將提高。

歐洲放射治療市場分析

  • 歐洲癌症盛行率上升、調強放射治療 (IMRT)、立體定位放射治療 (SBRT) 和質子治療等先進放射治療技術的採用率不斷提高，以及成像和治療計劃系統的技術進步，是預計推動歐洲放射治療市場成長的關鍵驅動因素。
  • 對非侵入性和標靶癌症治療解決方案的需求不斷增長、對腫瘤學重點研發的投資不斷增加、放射治療設備的不斷創新以及政府對癌症護理基礎設施的支持性政策和資金等關鍵因素正在推動歐洲放射治療市場的成長。
  • 2024 年，德國佔據歐洲放射治療市場的主導地位，市佔率為 28.24%。由於癌症盛行率不斷上升、癌症治療放射治療的新技術以及放射治療設備和程序的採用率不斷提高，預計在 2025 年至 2032 年的預測期內，德國的複合年增長率將達到 10.5%。
  • 外束放射治療領域在 2024 年佔據市場主導地位，佔有 62.47% 的市場份額，在 2025 年至 2032 年的預測期內，複合年增長率為 10.0%。推動了癌症盛行率的不斷上升、癌症治療放射治療的新技術以及放射治療設備和程序的日益普及。

報告範圍和歐洲放射治療市場細分

屬性

歐洲放射治療關鍵市場洞察

涵蓋的領域
  • 依產品及服務：服務、產品、軟體
  • 依類型：體外放射治療、內照射放射治療、全身放射治療/放射性藥物、其他
  • 依應用：乳癌、肺癌、攝護腺癌、大腸直腸癌、淋巴瘤、肝癌、甲狀腺癌、腦癌、子宮頸癌、脊椎癌、其他
  • 依最終使用者分類：醫院、放射治療中心、專科診所、學術和研究機構、其他
  • 按分銷管道：直接投標、第三方分銷商、線上平台、其他

覆蓋國家

歐洲

  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 瑞士
  • 荷蘭
  • 波蘭
  • 火雞
  • 歐洲其他地區

主要市場參與者
  • 西門子醫療有限公司（德國）
  • 日立有限公司（日本）
  • 通用電氣公司（美國）
  • Koninklijke Philips NV（荷蘭）
  • Elekta（瑞典）
  • 蔡司國際（德國）
  • IBA Worldwide（比利時）
  • 佳能醫療系統株式會社（日本）
  • Accuray Incorporated（美國）
  • Mevion醫療體系（美國）
  • Brainlab（德國）
  • BEBIG醫療（德國）
  • LinaTech公司（中國）
  • 聯影醫療股份有限公司 (中國)
  • Eckert & Ziegler BEBIG（德國）
  • ViewRay Systems, Inc.（美國）
  • Nordion（加拿大）公司（加拿大）

市場機會
  • 癌症治療醫療支出增加
  • 政府加大對癌症治療的投入
  • 提高患者對癌症治療的認識

加值資料資訊集

除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括深度專家分析、患者流行病學、管道分析、定價分析和監管框架。

歐洲放射治療市場趨勢

“醫療保健系統對先進、非侵入性和精準癌症治療解決方案的需求不斷增長”

  • 隨著癌症盛行率的上升、患者意識的提升以及整個醫療保健系統向個人化醫療的轉變，對先進、非侵入性和精準癌症治療解決方案的需求正在快速增長。放射治療技術透過提供有針對性、有效的治療方案來滿足這些需求，從而最大限度地減少副作用並改善患者預後。
  • 隨著醫療保健提供者致力於減少治療相關併發症並提高護理質量，他們越來越傾向於整合先進的放射治療技術，例如影像導引放射治療 (IGRT)、調強放射治療 (IMRT) 和質子治療。這種轉變對於滿足嚴格的監管標準、提高治療效果以及支持歐洲轉型為價值導向型醫療至關重要。
  • 西門子醫療、醫科達、瓦里安（西門子旗下公司）和 Accuray 等主要產業參與者正在大力加強研發力度，開發具有更高精度、自動化和與人工智慧整合的尖端放射治療設備和軟體，進一步推動創新和市場成長
  • 影像、治療計劃和遞送技術（例如自適應放射治療、立體定位放射外科 (SRS) 和質子束治療）的進步正在提高治療的準確性、患者安全性和手術效率。這些創新正在推動放射治療技術在醫院和專科中心的廣泛應用，並支持歐洲放射治療市場的擴張。

歐洲放射治療市場動態

“癌症盛行率不斷上升”

  • 受癌症盛行率上升、患者意識增強以及轉向個人化、微創療法的推動，歐洲對先進、精準且患者友好的癌症治療解決方案的需求日益增長，這給醫療服務提供者和製造商帶來了壓力，迫使他們創新和升級醫院、專科診所和癌症中心的放射治療技術。為了滿足這一需求，各公司正在加快對下一代放射治療設備、軟體和治療計劃系統的投資，以提供更高的準確性、更好的患者治療效果和更精簡的工作流程。這些進步正在建構更聰明、更有效率的腫瘤治療生態系統，就像精準醫療正在重塑醫療服務一樣。
  • 例如，2025年初，來自領先腫瘤學機構的研究人員強調，質子治療和自適應放射治療作為癌症治療的變革性方法，其重要性日益凸顯。他們的研究強調了這些尖端技術在最大限度地減少健康組織受到的輻射照射，同時增強腫瘤靶向性，從而顯著改善患者生活品質的優勢。報告強調，在不斷發展的癌症治療格局中，將先進的影像技術和人工智慧驅動的治療計劃整合起來的重要性日益凸顯，它們作為個性化和整合治療方案，在提高放射治療療效方面發揮著關鍵作用。
  • 這些投資不僅改變了放射治療的現狀，也推動了先進治療模式在新興市場以及兒童腫瘤和罕見癌症等高成長領域的更廣泛應用。西門子、醫科達、瓦里安（西門子）和Accuracy等領導企業正在大力投資創新放射治療系統、人工智慧軟體和以患者為中心的解決方案，以保持競爭優勢並提升各應用領域的治療效果。
  • 此外，各國政府、研究機構和私人企業持續致力於改善癌症治療基礎設施並推動放射治療創新，這在塑造更有效率的歐洲腫瘤市場方面發揮關鍵作用。這些措施正在將先進的放射治療確立為現代癌症治療的基石，並成為向更安全、更精準、更以患者為中心的治療模式轉型的主要成長動力。

克制/挑戰

“缺乏熟練且經過認證的專業人員”

  • 缺乏熟練且獲得認證的放射治療專業人員仍然是限制全球先進放射治療技術發展和廣泛應用的最主要因素之一。放射治療需要訓練有素的腫瘤科醫生、醫學物理學家、劑量師和放射治療師，以確保精準的治療計劃、安全的治療實施和有效的患者管理——而這些技能目前尤其在發展中地區較為匱乏。
  • 此外，現代放射治療技術（例如調強放射治療 (IMRT)、立體定位放射外科 (SRS) 和質子治療）的複雜性要求持續的專業培訓和認證才能跟上技術進步的步伐。許多國家缺乏標準化的培訓計畫和認證框架，這加劇了這個問題，常常導致治療效果不佳，並限制了充分利用先進放射治療設備的能力。
  • 例如，國際原子能總署（IAEA）在2025年3月的一項研究強調，許多中低收入國家面臨訓練有素的放射治療人員嚴重短缺的問題，這嚴重延誤了新治療技術的實施，並限制了患者獲得優質醫療服務的機會。報告強調，迫切需要進行國際合作，制定適用於資源有限地區的可擴展培訓計畫和認證途徑。
  • 同樣，美國放射腫瘤學會 (ASTRO) 在 2024 年進行的一項調查顯示，儘管美國各地對先進放射治療系統的投資不斷增加，但許多中心仍難以招募和留住合格的醫學物理學家和劑量師，這直接影響治療效率和患者吞吐量。
  • 熟練專業人員的短缺，加上放射治療技術日益複雜，繼續阻礙放射治療服務的廣泛應用和最佳利用。儘管教育、認證和遠距培訓方面的工作正在持續推進，但應對這些勞動力挑戰對於充分釋放歐洲放射治療市場的潛力仍然至關重要。

歐洲放射治療市場範圍

市場根據產品、應用類型、程序類型、可用性、最終用戶和分銷管道進行細分

• 按產品和服務

根據產品和服務，歐洲放射治療市場細分為服務、產品和軟體。預計到2025年，服務領域將佔據市場主導地位，市場份額將達到55.95%，在2025年至2032年的預測期內，複合年增長率最高可達9.9%，這主要得益於癌症患病率的上升、癌症放射治療新技術的出現以及以及放射治療設備和程序的普及。

  • 按類型

根據類型，歐洲放射治療市場細分為外束放射治療、內束放射治療、全身放射治療/放射性藥物及其他。預計到2025年，外束放射治療領域將佔據市場主導地位，市場份額將達到65.11%，在2025年至2032年的預測期內，複合年增長率最高可達9.9%，這主要得益於預計癌症治療醫療支出將增加、政府加大對癌症治療的投入以及患者對癌症治療認知度的提高。

  • 按應用

根據應用，歐洲放射治療市場細分為乳癌、肺癌、攝護腺癌、大腸癌、淋巴瘤、肝癌、甲狀腺癌、腦癌、子宮頸癌、脊椎癌等。預計到2025年，乳癌領域將佔據市場主導地位，市場份額將達到21.94%，在2025年至2032年的預測期內，其最高複合年增長率將達到10.9%，這得益於癌症患病率的不斷上升、癌症放射治療新技術的出現以及放射治療設備和程序的日益普及。

  • 按最終用戶

根據最終用戶，歐洲放射治療市場可細分為醫院、放射治療中心、專科診所、學術及研究機構等。 2024年，醫院佔據63.55%的市場份額，並在2025年至2032年的預測期內以10.1%的複合年增長率增長，這主要得益於癌症治療醫療支出的增加、政府加大對癌症治療的投入以及患者對癌症治療認知度的提高。

  • 按分銷管道

根據分銷管道，歐洲放射治療市場可細分為直接招標、第三方分銷商和其他。 2024年，直接招標市場佔據主導地位，市佔率達81.41%。受癌症盛行率上升、放射治療新技術應用於癌症治療以及放射治療設備和程序日益普及的推動，2025年至2032年的預測期內，直接招標市場將以9.8%的複合年增長率增長。

歐洲放射治療市場區域分析

  • 歐洲德國放射治療市場規模預計將從 2024 年的 6.8 億美元增至 2032 年的 14.7 億美元，在 2025 年至 2032 年的預測期內，複合年增長率為 10.5%
  • 德國將其GDP的很大一部分用於醫療保健，確保為尖端癌症治療技術（包括先進的放射治療程序）提供充足的資金。相較之下，新興市場由於癌症盛行率上升以及人們對現代治療方案的認識而不斷提高，正在增加醫療保健支出。公共和私營部門的資金供應在擴大放射治療服務的可及性方面發揮著至關重要的作用。
  • 在歐洲，放射治療已廣泛普及，並已納入標準腫瘤治療。相較之下，在醫療基礎設施不斷發展的新興市場，受醫院網路擴張和醫療預算增加的推動，放射治療服務的可近性正在快速增長。隨著醫療體係日益集中化或私有化，對先進放射治療設備和軟體的投資增加，促進了市場成長，並提高了治療的可及性。

法國放射治療市場洞察

預計法國放射治療市場在 2025 年至 2032 年期間的複合年增長率將達到 10.4%，這主要得益於癌症治療的醫療支出預計增加、政府對癌症治療的舉措不斷增多以及患者對癌症治療的認識不斷提高。

英國放射治療市場洞察

英國 放射治療市場預計在 2025 年至 2032 年期間的複合年增長率將達到 10.1%，這主要得益於癌症治療的醫療支出預計增加、政府對癌症治療的舉措不斷增多以及患者對癌症治療的認識不斷提高。

歐洲放射治療市場佔有率

歐洲放射治療市場主要由知名公司主導，包括：

  • 西門子醫療有限公司（德國）
  • 日立有限公司（日本）
  • 通用電氣公司（美國）
  • Koninklijke Philips NV（荷蘭）
  • Elekta（瑞典）
  • 蔡司國際（德國）
  • IBA Worldwide（比利時）
  • 佳能醫療系統株式會社（日本）
  • Accuray Incorporated（美國）
  • Mevion醫療體系（美國）
  • Brainlab（德國）
  • BEBIG醫療（德國）
  • LinaTech公司（中國）
  • 聯影醫療股份有限公司 (中國)
  • Eckert & Ziegler BEBIG（德國）
  • ViewRay Systems, Inc.（美國）
  • Nordion（加拿大）公司（加拿大）

歐洲放射治療市場的最新發展

  • 2024 年 5 月，西門子醫療和瓦里安在 ESTRO 2024 上展示了放射腫瘤學領域的新進展，包括 HyperSight 成像、ARIA CORE 腫瘤管理以及更易於放射治療的 MRI
  • 2024年9月，Ballad Health與西門子醫療旗下的瓦里安達成一項為期10年、價值2.6億美元的合作，旨在革新阿巴拉契亞高地地區的癌症治療。此次合作將為六家癌症中心帶來先進的腫瘤技術，包括直線加速器和數位化管理解決方案，從而提高農村社區的治療精準度和可及性。
  • 2023年，日立透過雲端、人工智慧和物聯網解決方案拓展了其數位系統與服務 (DSS) 業務。這包括進一步開發其 Lumada 平台，並整合 IT 服務公司 EuropeLogic。
  • 2025年5月，GE醫療集團將在ESTRO 2025上大幅擴展其放射腫瘤學產品組合，推出全新的AI賦能解決方案，包括高效器官分割的MR Contour DL。此外，他們也正在增強其智慧放射治療(iRT)軟體，以整合MR和AI驅動的工作流程，旨在實現更精準、更及時的癌症治療。
  • 2024年4月，GE醫療集團完成了歐洲醫學影像分析和人工智慧解決方案供應商MIM Software的收購。此次策略性收購將MIM Software先進的影像分析、工作流程自動化以及人工智慧分割和輪廓勾畫工具整合到GE醫療集團的精準醫療策略中，從而增強GE醫療集團的產品組合，尤其是在放射腫瘤學領域。

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE RADIOTHERAPY MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT & SERVICES SEGMENT LIFELINE CURVE

2.8 MARKET END USER COVERAGE GRID

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTLE ANALYSIS

4.2 PORTER'S FIVE FORCES MODEL

4.3 PRICING ANALYSIS

5 REGULATORY GUIDELINES FOR RADIOTHERAPY

5.1 U.S REGULATORY GUIDELINES FOR RADIOTHERAPY

5.2 EUROPE REGULATORY GUIDELINE FOR RADIOTHERAPY

5.3 INDIA REGULATORY GUIDELINE FOR RADIOTHERAPY

5.4 CLEARANCE OF THE UNIT BY AERB (TYPE APPROVED OR NOC-ISSUED EQUIPMENT)

5.5 CHINA REGULATORY GUIDELINE FOR RADIOTHERAPY

5.6 ELEMENTS OF RADIATION PROTECTION PROGRAM -

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 GROWING PREVALENCE OF CANCER DISEASE

6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT

6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES

6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES

6.2 RESTRAINTS

6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS

6.2.2 HIGH COST OF TREATMENT AND RADIOTHERAPY PROCEDURE

6.3 OPPORTUNITIES

6.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER TREATMENT

6.3.2 GROWING GOVERNMENT INITIATIVES TOWARD CANCER TREATMENT

6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT

6.4 CHALLENGES

6.4.1 STRICT REGULATIONS AND STANDARDS FOR APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS

6.4.2 RISK OF RADIATION EXPOSURE

7 EUROPE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES

7.1 OVERVIEW

7.2 SERVICES

7.3 PRODUCT

7.4 SOFTWARE

8 EUROPE RADIOTHERAPY MARKET, BY TYPE

8.1 OVERVIEW

8.2 EXTERNAL-BEAM RADIATION THERAPY

8.3 INTERNAL RADIATION THERAPY

8.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS

8.5 OTHERS

9 EUROPE RADIOTHERAPY MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 BREAST CANCER

9.3 LUNG CANCER

9.4 PROSTATE CANCER

9.5 COLORECTAL CANCER

9.6 LYMPHOMA

9.7 LIVER CANCER

9.8 THYROID CANCER

9.9 BRAIN CANCER

9.1 CERVICAL CANCER

9.11 SPINE CANCER

9.12 OTHERS

10 EUROPE RADIOTHERAPY MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 RADIATION THERAPY CENTERS

10.4 SPECIALTY CLINICS

10.5 OTHERS

11 EUROPE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDERS

11.3 THIRD PARTY DISTRIBUTORS

11.4 OTHERS

12 EUROPE RADIOTHERAPY MARKET, BY REGION

12.1 EUROPE

12.1.1 GERMANY

12.1.2 FRANCE

12.1.3 U.K.

12.1.4 ITALY

12.1.5 SPAIN

12.1.6 RUSSIA

12.1.7 TURKEY

12.1.8 BELGIUM

12.1.9 NETHERLANDS

12.1.10 SWITZERLAND

12.1.11 SWEDEN

12.1.12 REST OF EUROPE

13 EUROPE RADIOTHERAPY MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: EUROPE

14 SWOT ANALYSIS

15 EUROPE RADIOTHERAPY MARKET, COMPANY PROFILE

15.1 SIEMENS HEALTHCARE GMBH

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 HITACHI, LTD.

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 GENERAL ELECTRIC COMPANY

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENTS

15.4 KONINKLIJKE PHILIPS N.V.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENTS

15.5 ELEKTA

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 ACCURACY INCORPORATED

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 BEBIG MEDICAL.

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENTS

15.8 BRAINLAB

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENTS

15.9 CANON MEDICAL SYSTEMS CORPORATION

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.9.4 RECENT DEVELOPMENTS

15.1 ECKERT & ZIEGLER BEBIG

15.10.1 COMPANY SNAPSHOT

15.10.2 REVENUE ANALYSIS

15.10.3 PRODUCT PORTFOLIO

15.10.4 RECENT DEVELOPMENTS

15.11 IBA WORLDWIDE

15.11.1 COMPANY SNAPSHOT

15.11.2 REVENUE ANALYSIS

15.11.3 PRODUCT PORTFOLIO

15.11.4 RECENT DEVELOPMENTS

15.12 LINATECH INC

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 MEVION MEDICAL SYSTEMS

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENTS

15.14 NORDION (CANADA) INC. (A SUBSIDIARY OF SOTERA HEALTH)

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENTS

15.15 P-CURE

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 UNITED IMAGING HEALTHCARE CO., LTD

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 VIEWRAY SYSTEMS, INC.

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENT

15.18 ZEISS INTERNATIONAL

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 COMPANY SHARE ANALYSIS

15.18.4 PRODUCT PORTFOLIO

15.18.5 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

表格列表

TABLE 1 EUROPE RADIOTHERAPY MARKET: AVERAGE SELLING PRICE OF EQUIPMENT, SOFTWARE AND SERVICES

TABLE 2 EUROPE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 3 EUROPE SERVICES IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 4 EUROPE PRODUCT IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 5 EUROPE PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 6 EUROPE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 7 EUROPE PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 8 EUROPE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 9 EUROPE SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 10 EUROPE SOFTWARE IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 11 EUROPE SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 12 EUROPE RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 13 EUROPE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 14 EUROPE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 15 EUROPE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 16 EUROPE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 17 EUROPE SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 18 EUROPE OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 19 EUROPE RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 20 EUROPE BREAST CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 21 EUROPE LUNG CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 22 EUROPE PROSTATE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 23 EUROPE COLORECTAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 24 EUROPE LYMPHOMA IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 25 EUROPE LIVER CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 26 EUROPE THYROID CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 27 EUROPE BRAIN CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 28 EUROPE CERVICAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 29 EUROPE SPINE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 30 EUROPE OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 31 EUROPE RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 32 EUROPE HOSPITALS IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 33 EUROPE RADIATION THERAPY CENTERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 34 EUROPE SPECIALTY CLINICS IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 35 EUROPE OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 36 EUROPE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 37 EUROPE DIRECT TENDERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 38 EUROPE THIRD PARTY DISTRIBUTORS IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 39 EUROPE OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 40 EUROPE RADIOTHERAPY MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 41 EUROPE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 42 EUROPE PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 43 EUROPE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 44 EUROPE PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 45 EUROPE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 46 EUROPE SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 47 EUROPE SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 48 EUROPE RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 49 EUROPE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 50 EUROPE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 51 EUROPE RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 52 EUROPE RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 53 EUROPE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 54 GERMANY RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 55 GERMANY PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 56 GERMANY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 57 GERMANY PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 58 GERMANY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 59 GERMANY SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 60 GERMANY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 61 GERMANY RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 62 GERMANY EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 63 GERMANY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 64 GERMANY RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 65 GERMANY RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 66 GERMANY RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 67 FRANCE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 68 FRANCE PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 69 FRANCE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 70 FRANCE PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 71 FRANCE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 72 FRANCE SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 73 FRANCE SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 74 FRANCE RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 FRANCE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 76 FRANCE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 77 FRANCE RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 78 FRANCE RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 79 FRANCE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 80 U.K. RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 81 U.K. PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 82 U.K. EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 83 U.K. PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 84 U.K. INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 85 U.K. SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 86 U.K. SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 87 U.K. RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 88 U.K. EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 89 U.K. INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 90 U.K. RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 91 U.K. RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 92 U.K. RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 93 ITALY RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 94 ITALY PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 95 ITALY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 96 ITALY PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 97 ITALY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 98 ITALY SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 99 ITALY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 100 ITALY RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 101 ITALY EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 102 ITALY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 103 ITALY RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 104 ITALY RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 105 ITALY RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 106 SPAIN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 107 SPAIN PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 108 SPAIN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 109 SPAIN PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 110 SPAIN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 111 SPAIN SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 112 SPAIN SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 113 SPAIN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 114 SPAIN EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 115 SPAIN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 116 SPAIN RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 117 SPAIN RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 118 SPAIN RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 119 RUSSIA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 120 RUSSIA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 121 RUSSIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 122 RUSSIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 123 RUSSIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 124 RUSSIA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 125 RUSSIA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 126 RUSSIA RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 127 RUSSIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 128 RUSSIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 129 RUSSIA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 130 RUSSIA RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 131 RUSSIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 132 TURKEY RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 133 TURKEY PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 134 TURKEY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 135 TURKEY PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 136 TURKEY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 137 TURKEY SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 138 TURKEY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 139 TURKEY RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 140 TURKEY EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 141 TURKEY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 142 TURKEY RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 143 TURKEY RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 144 TURKEY RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 145 BELGIUM RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 146 BELGIUM PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 147 BELGIUM EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 148 BELGIUM PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 149 BELGIUM INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 150 BELGIUM SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 151 BELGIUM SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 152 BELGIUM RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 BELGIUM EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 154 BELGIUM INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 155 BELGIUM RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 156 BELGIUM RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 157 BELGIUM RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 158 NETHERLANDS RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 159 NETHERLANDS PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 160 NETHERLANDS EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 161 NETHERLANDS PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 162 NETHERLANDS INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 163 NETHERLANDS SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 164 NETHERLANDS SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 165 NETHERLANDS RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 166 NETHERLANDS EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 167 NETHERLANDS INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 168 NETHERLANDS RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 169 NETHERLANDS RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 170 NETHERLANDS RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 171 SWITZERLAND RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 172 SWITZERLAND PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 173 SWITZERLAND EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 174 SWITZERLAND PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 175 SWITZERLAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 176 SWITZERLAND SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 177 SWITZERLAND SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 178 SWITZERLAND RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 179 SWITZERLAND EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 180 SWITZERLAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 181 SWITZERLAND RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 182 SWITZERLAND RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 183 SWITZERLAND RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 184 SWEDEN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 185 SWEDEN PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 186 SWEDEN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 187 SWEDEN PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 188 SWEDEN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 189 SWEDEN SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 190 SWEDEN SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

TABLE 191 SWEDEN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 192 SWEDEN EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 193 SWEDEN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 194 SWEDEN RADIOTHERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 195 SWEDEN RADIOTHERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 196 SWEDEN RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 197 REST OF EUROPE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2018-2032 (USD THOUSAND)

图片列表

FIGURE 1 EUROPE RADIOTHERAPY MARKET: SEGMENTATION

FIGURE 2 EUROPE RADIOTHERAPY MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE RADIOTHERAPY MARKET: DROC ANALYSIS

FIGURE 4 EUROPE RADIOTHERAPY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE RADIOTHERAPY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE RADIOTHERAPY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE RADIOTHERAPY MARKET: MULTIVARIATE MODELLING

FIGURE 8 EUROPE RADIOTHERAPY MARKET: PRODUCT & SERVICES LIFELINE CURVE

FIGURE 9 EUROPE RADIOTHERAPY MARKET: MARKET END USER COVERAGE GRID

FIGURE 10 EUROPE RADIOTHERAPY MARKET: DBMR MARKET POSITION GRID

FIGURE 11 EUROPE RADIOTHERAPY MARKET: VENDOR SHARE ANALYSIS

FIGURE 12 EUROPE RADIOTHERAPY MARKET: SEGMENTATION

FIGURE 13 EUROPE RADIOTHERAPY MARKET: EXECUTIVE SUMMARY

FIGURE 14 EUROPE RADIOTHERAPY MARKET: STRATEGIC DECISIONS

FIGURE 15 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT IS EXPECTED TO DRIVE THE GROWTH OF THE EUROPE RADIOTHERAPY MARKET FROM 2025 TO 2032

FIGURE 16 THE SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE RADIOTHERAPY MARKET IN 2025 & 2032

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE RADIOTHERAPY MARKET

FIGURE 18 EUROPE RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, 2024

FIGURE 19 EUROPE RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, 2025-2032 (USD THOUSAND)

FIGURE 20 EUROPE RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, CAGR (2025-2032)

FIGURE 21 EUROPE RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE

FIGURE 22 EUROPE RADIOTHERAPY MARKET: BY TYPE, 2024

FIGURE 23 EUROPE RADIOTHERAPY MARKET: BY TYPE, 2025-2032 (USD THOUSAND)

FIGURE 24 EUROPE RADIOTHERAPY MARKET: BY TYPE, CAGR (2025-2032)

FIGURE 25 EUROPE RADIOTHERAPY MARKET: BY TYPE, LIFELINE CURVE

FIGURE 26 EUROPE RADIOTHERAPY MARKET: BY APPLICATION, 2024

FIGURE 27 EUROPE RADIOTHERAPY MARKET: BY APPLICATION, 2025-2032 (USD THOUSAND)

FIGURE 28 EUROPE RADIOTHERAPY MARKET: BY APPLICATION, CAGR (2025-2032)

FIGURE 29 EUROPE RADIOTHERAPY MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 30 EUROPE RADIOTHERAPY MARKET: BY END USER, 2024

FIGURE 31 EUROPE RADIOTHERAPY MARKET: BY END USER, 2025-2032 (USD THOUSAND)

FIGURE 32 EUROPE RADIOTHERAPY MARKET: BY END USER, CAGR (2025-2032)

FIGURE 33 EUROPE RADIOTHERAPY MARKET: BY END USER LIFELINE CURVE

FIGURE 34 EUROPE RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 35 EUROPE RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD THOUSAND)

FIGURE 36 EUROPE RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)

FIGURE 37 EUROPE RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 38 EUROPE RADIOTHERAPY MARKET: SNAPSHOT (2024)

FIGURE 39 EUROPE RADIOTHERAPY MARKET: COMPANY SHARE 2024 (%)

查看详细信息 Right Arrow

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

市场是基于 歐洲放射治療市場，依產品和服務（服務、產品和軟體）、類型（外束放射治療、內放射治療、全身放射治療/放射性藥物等）、應用（乳腺癌、肺癌、前列腺癌、結直腸癌、淋巴瘤、肝癌、甲狀腺癌、腦癌、子宮頸癌、脊柱癌等）、最終用戶（醫院、分銷 进行细分的。
在2024年，歐洲放射治療市場的规模估计为2.41 USD Billion美元。
歐洲放射治療市場预计将在2025年至2032年的预测期内以CAGR 9.7%的速度增长。
市场上的主要参与者包括Siemens Healthcare GmbH, Hitachi Ltd., General Electric Company, Koninklijke Philips N.V., Elekta。

浏览相关页面

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future